Skip to main content

Table 2 Regression analysis showing associated factors for TB/HIV co-infection, Northeastern Amhara, Ethiopia, 2015

From: TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study

Predictor variables

TB–HIV confection

COR (95 % CI), P value

AOR (95 % CI), P value

Yes N (%)

No N (%)

Total N

Sex

 Female

113 (25.7)

326 (74.3)

439

1.2 (0.9–1.6), 0.2

1.2 (0.9–1.6), 0.17

 Male

123 (22.3)

428 (77.7)

551

1

 

Age

 ≤24

44 (13.5)

282 (86.5)

326

0.9 (0.57–1.6), 0.85

0.9 (0.57–1.6), 0.85

 25–45

163 (29.4)

295 (70.6)

418

3.4 (2–5), 0.00

3.4 (2–5), 0.00

 ≥46

29 (14.1)

177 (85.9)

206

1

1

Types of TB

 PTB+

71 (36.2)

125 (63.8)

196

2.8 (1.9–4), 0.00

2.2 (1.4–3.3), 0.00

 PTB−

87 (26.2)

245 (73.8)

332

1.7 (1.2–2.5), 0.002

1.9 (1.3–2.8), 001

 EPTB

78 (16.9)

384 (83.1)

462

1

1

TB treatment outcome

 Unknown

4 (36.4)

7 (63.6)

11

2 (0.58–6.98), 0.26

2 (0.56–7.3), 0.23

 Transfer out

5 (16.7)

25 (83.3)

30

0.7 (0.26–1.8), 0.48

0.64 (0.23–1.75), 0.38

 Poor

39 (40.6)

57 (59.4)

96

2.4 (1.56–3.75), 0.00

2 (1.2–3.1), 0.003

Success

188 (22)

665 (78)

853

1

1

  1. AOR adjusted odds ratio, ART antiretroviral therapy, COR crude odds ratio, CPT co-trimoxazole preventive therapy, EPTB extra pulmonary TB, HIV human immunodeficiency virus, PTB− smears negative pulmonary TB, PTB+ smear-positive pulmonary TB, TB tuberculosis